Impaired leucocyte functions in diabetic patients

Diabetic Medicine

Volumn 14, Issue 1, 1997, Pages 29-34

  Delamaire, M ^a   Maugendre, D ^b   Moreno, M ^b   Le Goff, M C ^a   Allannic, H ^b   Genetet, B ^a  

^a Centre Regional de Transfusion Sanguine   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Diabetes mellitus; Hyperglycaemia; Polymorphonuclear neutrophils; Vascular complications

Indexed keywords

ADULT; AGED; ARTICLE; BACTERICIDAL ACTIVITY; CELL ADHESION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; VASCULAR DISEASE;

ADULT; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS;

EID: 0031035272     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V     Document Type: Article

References (32)

1. Moutschen MP, Schenn AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 1992; 18: 187-208.
2. Harlan JM. Leucocyte-endothelial interactions. Blood 1985; 65: 513-525.
3. Pyörälö K, Laakso M, Nusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987; 3: 463-524.
4. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314: 488-500.
5. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response, Immunol Today 1992; 13: 169-172.
6. MacGregor RR, Spagnulo PJ, Lentnek AL. Inhibition of granulocyte adherence by ethanol, prednisone and aspirin, measured with an assay system. N Engl J Med 1974; 291: 642-646.
7. Keizer H, Borst G, Figdor J, Spits C, Miedema H, Terhorst C, De Vries J. Biochemical and functional characteristics of the human leucocyte membrane antigen family LFA-1, MO-1. Eur J Immunol 1985; 15: 1142-1148.
8. Belloc F, Vincendeau P, Dumain P, Lacombe F, Freyburger G, Boisseau MR. Leukocyte activation study using flow cytometry. Basic Appl Histochem 1988; 32: 338-343.
9. Robert D Nelson, Quie PG, Simmons RL. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975; 115: 1650-1656.
10. Wehinger H, Hofaker M. Latex phagocytosis by polymorphonuclear leucocytes: in vitro and in vivo studies with a simple screening test. Eur J Ped 1976; 2: 125-132.
11. Park BH, Fikrif SM, Smithwick EM. Infection and nitrobluetetrazolium reduction by neutrophils. A diagnostic aid. Lancet 1968; 2: 532.
12. Descamps-Latscha B, Nguyen AT, Golub RM, Feuillet-Fieux MN. Chemiluminescence in microamounts of whole blood for investigation of the human phagocyte oxidative metabolism function. Annales d'Immunologie (Inst. Pasteur) 1982; 133C: 349-364.
13. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible detect in host defense in patients with poorly controlled diabetes. Diabetes 1978; 27: 677-681.
14. Tater D, Tepaut B, Bercovici JP, Youinou P. Polymorphonuclear cell derangements in type 1 diabetes. Horm Metab Res 1987; 19: 642-647.
15. Wautier JL, Weill D, Setiadi H, Wautier MP, Guillausseau PJ, Lenoble M, Caen JP. Effect of pentoxifylline on monocyte adhesion to endothelial cells in diabetic patients. In: Hakim J, Handell GL, eds. Pentoxifylline and Analogues: Effects on Leukocytes Function. Basle: Karger, 1990: 40-47.
16. Wilson RM, Reeves WG. Neutrophil phagocytosis and killing in insulin dependent diabetes. Clin Exp Immunol 1986; 63: 478-484.
17. Dziatkowiack H, Kowalska M, Denys A. Phagocytic and bactericidal activity of granulocytes in diabetic children. Diabetes 1982; 31: 1041-1043.
18. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of Diabetes. Diabetes Care 1992; 15: 256-260.
19. Nolan CM, Beaty HN, Bagdade JD. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 1978; 27: 889-894.
20. Kantar A, Wilkins G, Swoboda B, Littarru GP, Bertoli E, Catassi C, Coppa G, Giorgi PL. Alterations of the respiratory burst of polymorphonuclear leukocytes from diabetic children. Acta Paediatr Scand 1990; 79: 535-541.
21. Shah SV, Wallin JD, Eilen SD. Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab 1983; 57: 402-409.
22. Mowat AG, Baum J. Chemotaxis of polynuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971; 284: 621-627.
23. Hill HR, Sauls HS, Dettloffand JL, Quie PG. Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus. Clin Immunol Immunopathol 1974; 2: 395-403.
24. Hill HR, Augustine NH, Rallison ML, Santos JI. Defective monocyte chemotactic responses in diabetes mellitus. J Clin Immunol 1983; 3: 70-77.
25. Wilson RM. Neutrophil function in diabetes. Diabetic Med 1986; 3: 509-512.
26. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989; 38: 1031-1035.
27. Wilson RM, Tomlinson DR, Reeves WG. Neutrophil sorbitol production impairs oxidative killing in diabetes. Diabetic Med 1987; 4: 37-40.
28. Gin H. Infection et diabète. Rev Med Interne 1983; 14: 32-38.
29. Brisseau JM, Murat A, Raffi F, Ramée JF, Lucas V, Barrier JH, Guillon J. Diabète sucré et infections. Rev Med Interne 1989; 10: 435-441.
30. Bessman AN, Sapico FL. Infections in the diabetic patients: the role of immune dysfunction and pathogen virulence factors. I Diabetic Complications 1992; 6: 258-262.
31. Rayfield EJ, Ault MJ, Keush GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med 1982; 72: 439-450.
32. Kashima K, Sato N, Tanaka M, Shimomura Y, Kobayashi I, Mori M. Aldose reductase inhibitor improves an impaired neutrophil bactericidal function from streptozotocin-induced diabetic rats. Diabetes 1993; 42: (suppl 1): 198A.